{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-101673","form_type":"8-K","ticker":"KYMR","cik":"0001815442","company_name":"Kymera Therapeutics, Inc.","filed_at":"2022-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.443542+00:00","generated_at":"2026-06-26T08:17:49.953428+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Kymera Therapeutics director Steven Hall not standing for reelection at 2022 annual meeting","bullets":["Director Steven Hall informed board he will not stand for reelection at 2022 annual meeting.","Hall's departure is not due to any disagreement with the company.","Hall served on the Compensation Committee; company thanks him for service.","No replacement announced; Hall will serve until end of his current term."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-101673","json":"https://secwatch.observer/filing/0001193125-22-101673.json","markdown":"https://secwatch.observer/filing/0001193125-22-101673.md","text":"https://secwatch.observer/filing/0001193125-22-101673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815442/000119312522101673/0001193125-22-101673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815442/000119312522101673/d291982d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T08:17:49.953428+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0261a2aef0","claim":"Steven Hall departed as Director at Kymera Therapeutics, Inc..","evidence_excerpt":"On April 6, 2022, Dr. Steven Hall, a member of the Board of Directors (the “Board”) of Kymera Therapeutics, Inc. (the “Company”) and the Compensation Committee of the Board, informed the Company that he does not intend to stand for reelection at the Company’s 2022 annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312522101673/0001193125-22-101673-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"does not intend to stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}